Ovulation induction and cancer risk

Fertility and Sterility

Volumn 83, Issue 2, 2005, Pages 261-274

  Brinton, Louise A ^a   Moghissi, Kamran S ^b   Scoccia, Bert ^c   Westhoff, Carolyn L ^d   Lamb, Emmet J ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

Cancer; Epidemiology; Fertility drugs; Infertility; Ovulation induction; Risk

Indexed keywords

ANTIESTROGEN; CLOMIFENE; CONTRACEPTIVE AGENT; FERTILITY PROMOTING AGENT; GONADOTROPIN DERIVATIVE; HORMONE; TAMOXIFEN;

BREAST CANCER; CANCER; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; COLON CANCER; COMPARATIVE STUDY; ENDOMETRIUM CANCER; FERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; INFERTILITY; MALE FERTILITY; MELANOMA; META ANALYSIS; OVARY CANCER; OVULATION; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; THYROID CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

EID: 13544275785     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.09.016     Document Type: Review

References (99)

1. D.K. Wysowski Use of fertility drugs in the United States, 1973 through 1991 Fertil Steril 60 1993 1096 1098
2. E. Stephen, A. Chandra Updated projections of infertility in the United States: 1995-2025 Fertil Steril 70 1998 30 34
3. M.F. Fathalla Incessant ovulation: a factor in ovarian neoplasia? Lancet 2 1971 163
4. B.E. Henderson, R.K. Ross, H.L. Judd Do regular ovulatory cycles increase breast cancer risk? Cancer 56 1985 1206 1208
5. H. Sovino, T. Sir-Petermann, L. Devoto Clomiphene citrate and ovulation induction Reprod Biomed Online 4 2002 303 310
6. L. Bernstein Epidemiology of endocrine-related risk factors for breast cancer J Mammary Gland Biol Neoplasia 7 2002 3 15
7. F. Modugno, R.B. Ness, J.E. Wheeler Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness Ann Epidemiol 11 2001 568 574
8. A. Akhmedkhanov, A. Zeleniuch-Jacquotte, P. Toniolo Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives Ann NY Acad Sci 943 2001 296 315
9. C.B. Coulam, J.F. Annegers, J.S. Kranz Chronic anovulation syndrome and associated neoplasia Obstet Gynecol 61 1983 403 407
10. E. Dahlgren, L.G. Friberg, S. Johansson, B. Lindstrom, A. Oden, G. Samsioe Endometrial carcinoma; ovarian dysfunction--a risk factor in young women Eur J Obstet Gynecol Reprod Biol 41 1991 143 150
11. L.G. Escobedo, N.C. Lee, H.B. Peterson, P.A. Wingo Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women Obstet Gynecol 77 1991 124 128
12. B. Modan, E. Ron, L. Lerner-Geva, T. Blumstein, J. Menczer, J. Rabinovici Cancer incidence in a cohort of infertile women Am J Epidemiol 147 1998 1038 1042
13. J.A. Baron, E. Weiderpass, P.A. Newcomb, M. Stampfer, L. Titus-Ernstoff, K.M. Egan Metabolic disorders and breast cancer risk (United States) Cancer Causes Control 12 2001 875 880
14. L.D. Cowan, L. Gordis, J.A. Tonascia, G. Seegar-Jones Breast cancer incidence in women with a history of progesterone deficiency Am J Epidemiol 114 1981 209 217
15. J. Dor, L. Lerner-Geva, J. Rabinovici, A. Chetrit, D. Levran, B. Lunenfeld Cancer incidence in a cohort of infertile women who underwent in vitro fertilization Fertil Steril 77 2002 324 327
16. M. Moseson, K. Koenig, R.E. Shore, B.S. Pasternack The influence of medical conditions associated with hormones on the risk of breast cancer Int J Epidemiol 22 1993 1000 1009
17. G. Potashnik, L. Lerner-Geva, L. Genkin, A. Chetrit, B. Lunenfeld, A. Porath Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study Fertil Steril 71 1999 853 859
18. E. Ron, B. Lunenfeld, J. Menczer, T. Blumstein, L. Katz, G. Oelsner Cancer incidence in a cohort of infertile women Am J Epidemiol 125 1987 780 790
19. A. Venn, L. Watson, F. Bruinsma, G. Giles, D. Healy Risk of cancer after use of fertility drugs with in-vitro fertilisation Lancet 354 1999 1586 1590
20. C. Borgfeldt, E. Andolf Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis Acta Obstet Gynecol Scand 83 2004 395 400
21. L.A. Brinton, E.J. Lamb, K.S. Moghissi, B. Scoccia, M.D. Althuis, J.E. Mabie Ovarian cancer risk associated with varying causes of infertility Fertil Steril 82 2004 405 414
22. L.A. Brinton, G. Gridley, I. Persson, J. Baron, A. Bergqvist Cancer risk after a hospital discharge diagnosis of endometriosis Am J Obstet Gynecol 176 1997 572 579
23. L. Duczman, M.L. Ballweg Endometriosis and cancer: what is the connection? Endometriosis Association newsletter 1999 20
24. R.B. Ness, D.W. Cramer, M.T. Goodman, S. Kruger Kjaer, K. Mallin, B.J. Mosgaard Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies Am J Epidemiol 155 2003 217 224
25. H.A. Risch, G.R. Howe Pelvic inflammatory disease and the risk of epithelial ovarian cancer Cancer Epidemiol Biomarkers Prev 4 1995 447 451
26. X. Shu, L.A. Brinton, Y.T. Gao, J.M. Yuan Population-based case-control study of ovarian cancer in Shanghai Cancer Res 49 1989 3670 3674
27. A.S. Whittemore, R. Harris, J. Itnyre Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies II. Invasive epithelial ovarian cancers in white women Am J Epidemiol 136 1992 1184 1203
28. L.A. Brinton, E.J. Lamb, K.S. Moghissi, B. Scoccia, M.D. Althuis, J.E. Mabie Ovarian cancer risk after use of ovulation-stimulating drugs Obstet Gynecol 103 2004 1194 1203
29. OMEGA Project Group H. Klip, C.W. Burger, F.E. van Leeuwen Risk of hormone-related cancers after ovarian stimulation for in-vitro fertilisation in a cohort of 25,152 women H. Klip Long-term health effects of subfertility treatment 2002 PrintPartners Ipskamp BV Enschede, The Netherlands 55-82
30. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, S.G. Self Ovarian tumors in a cohort of infertile women N Engl J Med 331 1994 771 776
31. R. Burkman, M. Tang, K. Malone, P. Marchbanks, J. McDonald, S. Folger Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study Fertil Steril 79 2003 844 851
32. I.F. Adewole, I.A. Babarinsa, J.O. Thomas, A.B. Ajayi Ovarian cancer associated with ovulation induction: a case report Afr J Med Sci 26 1997 203 204
33. J. Balasch, J. Pahisa, M. Marquez, J. Ordi, F. Fabregues, B. Puerto Metastatic ovarian stromosis in an in-vitro fertilization patient Hum Reprod 8 1993 2075 2077
34. J. Dietl Ovulation and ovarian cancer Lancet 338 1991 445
35. P.N. Fuller Malignant melanoma of the ovary and exposure to clomiphene citrate: a case report and review of the literature Am J Obstet Gynecol 180 1999 1499 1503
36. M.E. Hull, M. Kriner, E. Schneider, M. Maiman Ovarian cancer after successful ovulation induction: a case report J Reprod Med 41 1996 52 54
37. P. Lopes, A. Mensier Ovarian cancer and assisted reproductive technology Eur J Obstet Gynecol Reprod Biol 51 1993 171 173
38. L. Unkila-Kallio, A. Leminen, A. Tiitnen, P. Lehtovirta, T. Wahlstrom, O. Ylikorkala Malignant tumors of the ovary or the breast in association with infertility: a report of thirteen cases Acta Obstet Gynecol Scand 76 1997 177 181
39. W. Willemsen, R. Kruitwagen, B. Bastiaans, T. Hanselaar, R. Rolland Ovarian stimulation and granulosa-cell tumor Lancet 341 1993 986 988
40. A.S. Whittemore, R. Harris, J. Itnyre Collaborative Ovarian Cancer Group 2 Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies IV. The pathogenesis of epithelial ovarian cancer Am J Epidemiol 136 1992 1210 1220
41. J.J. Caro, C.B. Johanees, S.C. Hartz, R. Marrs, O.S. Miettinen Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies II. Invasive epithelial ovarian cancers in white women." Am J Epidemiol 137 1993 928 929
42. J. Cohen, R. Forman, S. Harlap, E. Johannisson, B. Lunenfeld, J. de Mouzon IFFS Expert Group Report on the Whittemore study related to the risk of ovarian cancer associated with use of infertility drugs Hum Reprod 8 1993 996 999
43. G. Del Priore, K. Robischon, W.R. Phipps Risk of ovarian cancer after treatment for infertility N Engl J Med 332 1995 1300
44. S. Shapiro Risk of ovarian cancer after treatment for infertility N Engl J Med 332 1995 1301
45. M.S. Croughan-Minihane, L. Camarano, S. Feigenbaum, H. Nelson, G.D. Adamson, M.M. Cadieus The risk of ovarian cancer associated with infertility and infertility treatments Fertil Steril 76 Suppl 1 2001 68
46. P. Doyle, N. Maconochie, V. Beral, A.J. Swerdlow, S.L. Tan Cancer incidence following treatment for infertility at a clinic in the UK Hum Reprod 17 2002 2209 2213
47. A. Shushan, O. Paltiel, J. Iscovich, U. Elchalal, T. Peretz, J.G. Schenker Human menopausal gonadotropin and the risk of epithelial ovarian cancer Fertil Steril 65 1996 13 18
48. S. Franceschi, C. La Vecchia, E. Negri, S. Guarneri, M. Montella, E. Conti Fertility drugs and risk of epithelial ovarian cancer in Italy Hum Reprod 9 1994 1673 1675
49. B.J. Mosgaard, O. Lidegaard, S.K. Kjaer, G. Schou, A.N. Anderson Inferility, fertility drugs, and invasive ovarian cancer: a case-control study Fertil Steril 67 1997 1005 1012
50. F. Parazzini, E. Negri, C. La Vecchia, S. Moroni, S. Franceschi, P.G. Crosignanci Treatment for infertility and risk of invasive epithelial ovarian cancer Hum Reprod 12 1997 2159 2161
51. F. Parazzini, C. Pelucchi, E. Negri, S. Franceschi, R. Talamini, M. Montella Use of fertility drugs and risk of ovarian cancer Hum Reprod 16 2001 1372 1375
52. G. Makrydimas, A. Sotiriadis, E. Paraskevaidis, N. Pavlidis, N. Agnantis, D. Lolis Clear cell ovarian carcinoma in a pregnant woman with a history of infertility, endometriosis and unsuccessful IVF treatment Eur J Gynaecol Oncol 24 2003 438 441
53. K. Tewari, G.S. Rose, K.D. Balderston, M. Porto, M.F. Kohler Fertility drugs and malignant germ-cell tumour of ovary in pregnancy Lancet 351 1998 957 958
54. B.J. Tennent, K.L. Shultz, J.P. Sundberg, W.G. Beamer Ovarian granulosa cell tumorigenesis in SWR-derived F1 hybrid mice: preneoplastic follicular abnormality and malignant disease progression Am J Obstet Gynecol 163 1990 625 634
55. M. Hahlin, N. Crona, F. Knutsson, P.O. Janson Human granulosa cell tumor: stimulation of steroidogenesis by gonadotropins in vitro Gynecol Oncol 40 1991 201 206
56. L. Unkila-Kallio, A. Leminen, A. Tiitinen, O. Ylikorkala Nationwide data on falling incidence of ovarian granulosa cell tumours concomitant with increasing use of ovulation inducers Hum Reprod 13 1998 2828 2830
57. F. Parazzini, E. Negri, C. La Vecchia, S. Moroni, A. Polatti, F. Chiaffarino Treatment for fertility and risk of ovarian tumors of borderline malignancy Gynecol Oncol 68 1998 226 228
58. F. Parazzini, C. La Vecchia, E.F.S. Negri, L. Tozzi Lifelong menstrual pattern and risk of breast cancer Oncology 50 1993 222 225
59. L. Arbour, S. Narod, G. Glendon, M. Pollak, R. Seymour, I. Miner In-vitro fertilisation and family history of breast cancer Lancet 344 1994 610 611
60. P. Bolton Bilateral breast cancer associated with clomiphene Lancet 2 1977 1176
61. A. Brzezinski, T. Peretz, S. Mor-Yosef, J.G. Shenker Ovarian stimulation and breast cancer: is there a link? Gynecol Oncol 52 1994 292 295
62. O. Jourdain, A. Avril, L. Mauriac, N. Quenel, E. Bussieres, D. Roux Breast cancer and in vitro fertilization About 32 cases Eur J Obstet Gynecol Reprod Biol 67 1996 47 52
63. L. Lerner-Geva, E. Geva, J. Lessing, A. Chetrit, B. Modan, A. Amit The possible association between in vitro fertilization treatments and cancer development Int J Gynecol Cancer 13 2003 23 27
64. A. Venn, L. Watson, J. Lumley, G. Giles, C. King, D. Healy Breast and ovarian cancer incidence after infertility and in vitro fertilisation Lancet 346 1995 995 1000
65. C. Braga, E. Negri, C. La Vecchia, F. Parazzini, L. Dal Masso, S. Franceschi Fertility treatment and risk of breast cancer Hum Reprod 11 1996 300 303
66. E. Ricci, F. Parazzini, E. Negri, S. Marsico, C. La Vecchia Fertility drugs and the risk of breast cancer Hum Reprod 14 1999 1653 1655
67. H.A. Weiss, R. Troisi, M.A. Rossing, D. Brogan, R.J. Coates, M.D. Gammon Fertility problems and breast cancer risk in young women: a case-control study in the United States Cancer Causes Control 9 1998 331 339
68. D. Healy, A. Venn Infertility medications and the risk of breast cancer Fertil Steril 79 2003 852 854
69. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, S.G. Self Risk of breast cancer in a cohort of infertile women Gynecol Oncol 60 1996 3 7
70. B. Fisher, J. Costantino, D. Wickerham, C. Redmond, M. Kavanah, W. Cronin Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1998 1371 1388
71. K.L. Terry, W.C. Willett, J.W. Rich-Edwards, K.B. Michels Clomiphene citrate use and reduced incidence of premenopausal breast cancer Am J Epidemiol 2004 159(Suppl 66):2615.
72. L.A. Brinton, B. Scoccia, K.S. Moghissi, C.L. Westhoff, M.D. Althuis, J.E. Mabie Breast cancer risk associated with ovulation-stimulating drugs Hum Reprod 19 2004 2005 2013
73. M. Lambe, C. Hsieh, D. Trichopoulos, A. Ekborn, M. Pavia, H.O. Adami Transient increase in the risk of breast cancer after giving birth N Engl J Med 331 1994 5 9
74. A. Venn, E. Hemminki, L. Watson, F. Bruinsma, D. Healy Mortality in a cohort of IVF patients Hum Reprod 16 2001 2691 2696
75. N. Siegelmann-Danieli, A. Tamir, H. Zohar, M.Z. Papa, L.L. Chetver, Z. Gallimidi Breast cancer in women with recent exposure to fertility medications is associated with poor prognostic features Ann Surg Oncol 10 2003 1031 1038
76. E. Miannay, J.J. Boutemy, M. Leroy-Billiard, J.P. Gasnault, J.L. Leroy The possible endometrial risk of ovarian stimulation Apropos of 3 cases J Gynecol Obstet Biol Reprod (Paris) 23 1994 35 38
77. A. Benshushan, O. Paltiel, A. Brzezinski, V. Tanos, M. Barchana, O. Shoshani Ovulation induction and risk of endometrial cancer: a pilot study Eur J Obstet Gynecol Reprod Biol 98 2001 53 57
78. Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, et al. Clomiphene citrate for ovulation induction and endometrial cancer risk. Am J Epidemiol (in press).
79. M. Varras, D. Polyzos, C. Akrivis Effects of tamoxifen on the human female genital tract: review of the literature Eur J Gynaecol Oncol 24 2003 258 268
80. L. Titus-Ernstoff An overview of the epidemiology of cutaneous melanoma Clin Plast Surg 27 2000 305 316 vii
81. E. Kuppens, W. Bergman, K. Welvaart, J.A. Bruijn, E. Scheffer Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy Melanoma Res 2 1992 71 74
82. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, S.G. Self Risk of cutaneous melanoma in a cohort of infertile women Melanoma Res 5 1995 123 127
83. P. Young, D. Purdie, L. Jackman, D. Molloy, A. Green A study of infertility treatment and melanoma Melanoma Res 11 2001 535 541
84. E.A. Holly, R.D. Cress, D.K. Ahn Cutaneous melanoma in women III. Reproductive factors and oral contraceptive use Am J Epidemiol 141 1995 943 950
85. N. Munoz, S. Franceschi, C. Bosetti, V. Moreno, R. Herrero, J.S. Smith Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study Lancet 359 2002 1093 1101
86. J.S. Smith, J. Green, D.G. Berrington, P. Appleby, J. Peto, M. Plummer Cervical cancer and use of hormonal contraceptives: a systematic review Lancet 361 2003 1159 1167
87. M.A. Rossing, J.R. Daling, B.S. Weiss, D.E. Moore, S.G. Self In situ and invasive cervical carcinoma in a cohort of infertile women Fertil Steril 65 1996 19 22
88. C. La Vecchia, E. Ron, S. Franceschi, Maso L. Dal, S.D. Mark, L. Chatenoud A pooled analysis of case-control studies of thyroid cancer III, Oral contraceptives, menopausal replacement therapy and other female hormones Cancer Causes Control 10 1999 157 166
89. L.N. Kolonel, J.H. Hankin, L.R. Wilkens, F.H. Fukunaga, M.W. Hinds An epidemiologic study of thyroid cancer in Hawaii Cancer Causes Control 1 1990 223 234
90. I. Bruchim, D. Kidron, A. Amiel, M. Altaras, M.D. Fejgin Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature Gynecol Oncol 77 2000 197 202
91. H. Matsui, S. Sekiya, T. Hando, N. Wake, Y. Tomoda Hydatidiform mole coexistent with a twin live fetus: a national collaborative study in Japan Hum Reprod 15 2000 608 611
92. F. Montes-de-Oca-Valero, L. Macara, A. Shaker Twin pregnancy with a complete hydatidiform mole and co-existing fetus following in-vitro fertilization: case report Hum Reprod 14 1999 2905 2907
93. C.I. Schneiderman, B. Waxman Clomid therapy and subsequent hydatidiform mole formation A case report. Obstet Gynecol 39 1972 787 788
94. P. Petignat, P. Vassilakos, A. Campana Are fertility drugs a risk factor for persistent trophoblastic tumour? Hum Reprod 17 2002 1610 1615
95. R.T. Burkman Reproductive hormones and cancer: ovarian and colon cancer Obstet Gynecol Clin North Am 29 2002 527 540
96. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
97. E. Deligeoroglou, E. Michailidis, G. Creatsas Oral contraceptives and reproductive system cancer Ann NY Acad Sci 997 2003 199 208
98. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies Lancet 347 1996 1713 1727
99. J.V. Lacey Jr, P.J. Mink, J.H. Lubin, M.E. Sherman, R. Troisi, P. Hartge Menopausal hormone replacement therapy and risk of ovarian cancer JAMA 288 2002 334 341